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Abstract
Background: Less is known about the association between general health-related quality of life (HRQoL) and oral 
HRQoL (OHRQoL) among patients with specific diseases. The aim of this study was to assess the association 
between patient-centered outcome measurements (HRQoL and OHRQoL) of oral cancer patients at least 6 months 
after treatment.
Material and Methods: HRQoL was measured with the 12-Item Short Form Health Survey (SF-12); OHRQoL was 
evaluated using the Oral Health Impact Profile (OHIP-14) and the Oral Impacts on Daily Performances (OIDP). 
Results: Higher OHRQoL scores were associated with lower SF-12 domains scores. The OHIP-14 explained 16.5 
% of the total variance of SF-12 Physical Component Summary (PCS) and the OIDP explained 16.1 %. In the SF-
12 Mental Component Summary (MCS), the total variance explained was 23.9 % by the OHIP-14 and 21.8 % by 
the OIDP.
Conclusions: There was a significant association between long-term OHRQoL and HRQoL in oral and oropha-
ryngeal cancer patients. These results may help to carry out new interventions aiming to improve patient s´ life 
overall.
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Introduction
There has been an increase in the use of health-related 
quality of life (HRQoL) measures to describe the out-
comes of health conditions and the effectiveness of their 
treatment. This concept is based on the perception of 
the individual (1) and helps to understand the impact of 
conditions, assesses the effect of their treatment on re-
ducing the disease burden, and provides an insight into 
which parameters are perceived as most important (2). 
Similarly, oral health-related quality of life (OHRQoL) 
focuses on the subject’s perception about how his/her 
oral health affects the quality of life. So, it would be 
logical to assume that OHRQoL is related to HRQoL, 
however, the links between OHRQoL and life overall 
should be demonstrated and not merely assumed (3). 
One possible way would be the concurrent use of OHR-
QoL measures with global ratings of general HRQoL 
since it would improve the understanding of the conse-
quences of oral disorders (4). 
HRQoL and OHRQoL have been shown to be associated 
in the general population (5) but this association may dif-
fer among patients with specific diseases. Head and neck 
cancer and the side-effects of the treatment have negative 
impact on many different aspects of quality of life pa-
tients over time (6). Oral cancer patients are considered 
different to patients suffering from other head and neck 
tumours because of the complex tri-dimensional anatomy 
of the mouth. Therefore, the use of site-specific analysis 
of outcomes, within the head and neck region, has been 
recommended (7). 
A recent review has been done about studies that looked 
at the HRQoL and OHRQoL of patients treated for oral 
and oropharyngeal cancer (8). However, little is known 
about the relationship between HRQoL and OHRQoL, 
because their findings of the studies were inconclusive. 
Most of them found positive correlations between HR-
QoL and OHRQoL (9-11) but Pierre et al. (12), did not 
find any correlation. Another way to address this rela-
tionship would be to use generic scales in order to include 
items that cover all major aspects of the person’s health 
(13). 
Therefore, the aim of this study was to assess the as-
sociation between long-term OHRQoL and HRQoL of 
a homogeneous group of oral and oropharyngeal cancer 
patients at least 6 months after treatment, in Granada, 
Spain.
Material and Methods
- Patients
This study is part of a larger project about factors asso-
ciated to the HRQoL in patients treated for oral cancer 
(14). This study was carried out at the Department of 
Maxillofacial Surgery of the Virgen de las Nieves Uni-
versity Hospital of Granada. Inclusion criteria for par-
ticipation in the study were: patients treated for oral or 
oropharyngeal cancer, at least six months have elapsed 
since treatment and the patients were free from recur-
rence of the disease. Exclusion criteria were: patients 
treated for other type of cancer or patients with inabil-
ity to complete or respond to questionnaires. A total of 
145 cases fulfilled the inclusion/exclusion criteria and 
were initially selected. Of them, 3 cases did not accept 
to participate in the study, giving 142 cases (97.9% ac-
ceptance rate) for the analysis.
As explained above, this study is part of a larger project 
(142 oral cancers and 142 control patients) (14). The initial 
sample size was established to detect a 0.3 standardized 
difference between cases and controls for the outcome 
variables (OHRQoL). For this present study, with 
only 142 cases and with the main aim of studying the 
association between OHRQoL and HRQoL, a sample 
size of 142 allows to detect as statistically significant 
(alpha=0.05), and according to Sample Power 2.0 (SPSS 
Inc., Chicago, IL), a relatively small correlation of 0.23, 
with 80% power (beta=0.20).
The study was approved by the Ethics Committee of the 
University of Granada and each participant signed an 
informed consent.
Collected data included HRQoL as the outcome vari-
able, OHRQoL as the main exposure variable and sex, 
age, social class, tumor site, clinical stage, follow-up, 
type of treatment, and presence of chronic diseases as 
covariates. The chronic diseases present were: diabetes, 
hypertension, high cholesterol levels, coronary heart 
diseases and lung diseases. 
- Measurement of HRQoL
The 12-Item Short Form Health Survey (SF-12) was 
used to evaluate HRQoL. The SF-12 is a shorter version 
of one the most commonly used general questionnaire 
(15), the 36-Item Short Form Health Survey (SF-36) 
(16). The version 2 of SF-12 permits the calculation of 
the 8 original SF-36 dimensions scores while version 
1 does not (17,18). This validated instrument (19) con-
tains 12 ítems with 3- or 5-point Likert scales result-
ing in 8 dimensions: physical functioning, role physical, 
bodily pain, general health, vitality, social functioning, 
role emotional and mental health. Physical Component 
Summary and Mental Component Summary are two 
summary scores calculated from these dimensions.
To compute SF-12 scores (19), first, we calculated the 
scores of the 8 dimensions and transformed them to a 
1-100 scale; then, we standardized them and finally did 
a linear transformation (multiplying the scores by 10 
and adding 50) to obtain a distribution of mean of 50 
and standard deviation of 10 in the reference general 
population. Computations of the aggregate summary 
components consist of multiplying the standardization 
by its respective physical or mental factor score coeffi-
cient and summing the eight products. The last step also 
involves transforming the aggregate physical and men-
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tal summary scores to the norm-based {50,10} scoring. 
We chose this specific method for the calculation using 
the SF-12 reference standards for the Spanish popula-
tion (17). Higher scores indicate better quality of life.
- Measurement of OHRQoL
OHRQoL was assessed through two widely used rele-
vant generic measures:  The Oral Health Impact Profile 
(OHIP-14) and the Oral Impacts on Daily Performances 
(OIDP). 
The OHIP-14 contains 14 items that are grouped into 
seven dimensions of impact: functional limitation, 
physical pain, psychological discomfort, physical dis-
ability, psychological disability, social disability and 
handicap. The participants respond to each item accord-
ing to the frequency of the impact on a 5-point Likert 
scale (ranging from 0 to 4): never, hardly ever, occa-
sionally, fairly often, and very often (20). The additive 
method (OHIP-AD) scoring method was used where the 
dimensions and the total score were calculated by sum-
ming the number of impacts reported.
The OIDP assesses the impact of oral conditions on 
eight daily life performances: eating, speaking, clean-
ing teeth, carrying out major work or role, social con-
tact, relaxing/sleeping, smiling, and emotional state. 
It takes into account the frequency and the severity of 
these impacts through Likert scales. For each perform-
ance a score is calculated by multiplying the frequency 
and severity scores. To get a percentage overall score, 
the sum of these performances scores is divided by the 
maximum possible score and multiplied by 100 (21,22).
For both the OHIP-14 and the OIDP, a higher score in-
dicates worse OHRQoL. The participants were inter-
viewed at least 6 months after the end of their oral cancer 
treatment. In order to avoid including the acute period 
of recovery in the time frame in cases of recent treat-
ment the recall period for both OHIP-14 and OIDP was 
changed from the usual 12 or 6 months to 1 month.
- Statistical analysis
Statistical analysis was performed using the SPSS ver-
sion 17.0 software package (SPSS Inc., Chicago, IL). 
Descriptive analysis of socio-demographic and clinical 
variables, SF-12, OHIP-14 and OIDP was followed by 
bivariate associations between the covariates and the 
SF-12 domains using the appropriate test according to 
the type of variable (Pearson’s or Spearman’s correla-
tion test). 
Linear regression models were carried out to evaluate the 
variance in SF-12 summary components (Physical Com-
ponent Summary score, Mental Component Summary 
score) by covariates registered (potential confounding 
factors). The two OHRQoL measures were used inter-
changeably in the models (they were tested one at a time 
in each multiple regression model). Model 1 was built by 
introducing age, sex and the statistically significant vari-
ables from the respective bivariate analysis (chronic dis-
eases). It assessed the adjusted association between the 
outcome (SF-12 summary components) and each one of 
the main exposures. Model 2 was built with the backward 
regression method to select the best model to predict SF-
12 Physical Component Summary score and SF-12 Men-
tal Component Summary from the different exposures. 
The level of significance for the removal of variables was 
set at p > 0.10. The coefficients of determination (r2) of the 
models were calculated. Models were run separately for 
the Physical Component Summary score and the Mental 
Component Summary score.
Authors have followed the STROBE guidelines for car-
rying out the study and for writing the paper (23).
Results
The social and clinical profile of the sample is presented 
in table 1. Of 142 patients, 91 were males (64.1 %), with 
Variable n (%) 
All
Sex 
   Male 
   Female 
142 (100) 
91 (64.1) 
51 (35.9) 
Age (years) 
   <50 
   50-65 
   >65 
   mean±sd 
18 (12.7) 
54 (38.0) 
70 (49.3) 
65.2±12.9 
Social Classa
   I 
   II 
   III 
   IV 
   V 
8 (5.6) 
8 (5.6) 
14 (9.9) 
35 (24.6) 
77 (54.2) 
Tumor site 
   Tongue 
   Buccal mucosa    
   Mouth floor  
   Gingiva 
   Oropharynx 
   Others 
50 (35.2) 
18 (12.7) 
16 (11.3) 
16 (11.3) 
16 (11.3) 
26 (18.3) 
Cancer stage 
   I 
   II 
   III 
   IV 
61 (43.0) 
25 (17.6) 
17 (12.0) 
39 (27.5) 
Follow-up (years) 
   6 months-5 
   6-10 
   11-15 
   >16 
   mean±sd 
92 (64.8) 
33 (23.2) 
13 (9.2) 
4 (2.8) 
4.9 (4.3) 
Treatment 
  Surgery
  Surgery+Radiotherapy
 Surgery+Radiotherapy+Chemotherapy
74 (52.1) 
43 (30.3) 
25 (17.6) 
Presence of chronic diseases
   No 
   1 
   2 or more 
29 (20.4) 
57 (40.1) 
56 (39.5) 
Table 1. Socio-demographic and clinical data variables de-
scription of oral cancer patients  (n=142).
a: In descending order.
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a mean age of 65.2 (standard deviation: 12.9) years. The 
lowest social class (V) was the most frequent in our 
sample. The tongue was the most frequent location for 
the cancer, the clinical stages I and IV the most preva-
lent, the mean follow-up was 4.0 (standard deviation: 
4.3) years and most patients underwent surgery without 
radiotherapy or chemotherapy. 
In relation to the HRQoL, the role physical and physical 
functioning were the SF-12 domains with worse scores. 
For OHRQoL, oral impacts predominantly affected the 
OHIP-14 dimensions on physical pain, physical dis-
ability and functional limitation while for the OIDP 
the items on difficulty eating, difficulty speaking and 
maintaining emotional status were the most prevalent 
(Table 2). 
The OHIP-14 and the OIDP were significantly corre-
lated with all domains and summary components of 
the SF-12. Being female and having chronic diseases 
were correlated with worse scores in all domains of SF-
12, with most of these associations being statistically 
significant (physical functioning, role physical, bodily 
pain, general health, vitality, mental health and Physi-
cal Component Summary with respect to sex and bod-
ily pain, general health, vitality, social functioning and 
Physical Component Summary with respect to chronic 
diseases). There were significant negative correlations 
between age and all SF-12 domains, being statistically 
significant in physical functioning, role physical, vital-
ity, social functioning and physical component sum-
mary. Neither social class nor clinical variables were 
significantly correlated with SF-12 (data not shown). 
Table 3 shows multiple linear regression analyses. 
Higher OHIP-14 and OIDP scores were associated with 
lower SF-12 scores. In adjusted analyses, for each high-
er unit in OHIP-14 or OIDP score, the Physical Compo-
nent Summary (PCS) was lower; the regression coeffi-
cients were -0.22 [-0.38-(-0.06)] units and -0.21 [-0.24-
(-0.03)] units respectively. After applying backward 
regression method (Model 2) age and sex were the only 
other variables that contributed to the models for PCS. 
There was hardly any change in the crude estimates: the 
coefficients were -0.22 [-0.38-(-0.07)] for the OHIP-14 
and -0.21 [-0.24-(-0.04)] for the OIDP. For the associa-
tion between OHRQoL and the MCS SF-12 component, 
lower MCS scores were associated with 1 higher unit 
in the OHRQoL measures, with the respective coeffi-
cients being -0.50 [-0.64-(-0.34)] for the OHIP-14 and 
-0.45 [-0.40-(-0.21)] for the OIDP. Following the same 
procedure (backward regression method) to identify 
significant predictors for the MCS of the SF-12, only 
the OHRQoL variables remained in the models (Model 
2). The inclusion of none of the other variables could 
improve the predictive ability of the models.   
According to the coefficient of determination (r2), the 
final model for the OHIP-14 explains 16.5% of the total 
variance of PCS and the respective figure for the model 
with the OIDP was 16.1%. In terms of the MCS, the to-
tal variance explained was 23.9% for the model with the 
OHIP-14 and 21.8% for the model with the OIDP.
Discussion
This study showed a significant association between 
long-term OHRQoL and HRQoL in oral and oropha-
ryngeal cancer patients after at least 6 months post-
treatment. This relationship remained significant after 
adjusting for significant covariates. Moreover, when 
looking for the best predictive model for the PCS and 
the MCS, OHRQoL measures were implicated in both 
models and were the only variables that remained in the 
final models for the MCS.
We found a significant association between OHRQoL 
and all SF-12 domains. This finding is in line with pre-
vious studies that showed correlations between global 
HRQoL and some head and neck cancer symptoms 
(9-11) or with the head and neck cancer symptom scale 
Variable mean (sd) 
SF-12a
   Physical Functioning 
   Role Physical 
   Bodily Pain 
   General Health 
   Vitality 
   Social Functioning 
   Role Emotional 
   Mental Health 
   Physical Component Summary 
   Mental Component Summary 
41.2 (13.0) 
40.7 (13.0) 
46.4 (9.2) 
44.0 (6.2) 
45.4 (7.9) 
43.0 (12.5) 
44.7 (12.6) 
44.8 (8.9) 
42.2 (12.0) 
45.8 (11.6) 
OHIP-14b
   Functional limitation 
   Physical pain 
   Psychological discomfort 
   Physical disability 
   Mental disability 
   Social disability 
   Handicap 
   Overall 
3.3 (2.2) 
3.9 (2.4) 
2.7 (2.5) 
3.7 (2.9) 
1.6 (2.2) 
1.6 (2.1) 
2.1 (2.1) 
18.9 (11.8) 
OIDPc
   Eating 
   Speaking 
   Cleaning teeth 
   Physical activities 
   Social Contact 
   Sleeping 
   Smiling 
   Emotional Status 
   Overall 
9.8 (7.2) 
7.8 (6.5) 
1.1 (3.3) 
2.4 (4.7) 
3.8 (6.2) 
2.8 (4.6) 
2.3 (5.0) 
6.4 (6.9) 
22.9 (18.3) 
Table 2. Health-related quality of life (SF-12) and oral 
health-related quality of life (OHIP-14 and OIDP) in oral 
cancer patients (n=142).
a SF-12: the 12-Item Short Form Health Survey; b OHIP-14: 
Oral Health Impact Profile; c OIDP: Oral Impacts on Daily 
Performances.
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(10). Pierre et al. (12), however, did not find such an 
association. Differences in the treatment regimen, the 
follow-up time or the questionnaires used for evaluation 
hinder the interpretation and comparison of published 
results on HRQoL and OHRQoL of oral cancer patients. 
We chose the two more widely used generic instru-
ments to evaluate the OHRQoL which could minimize 
the chance that the observed associations are due to the 
selected questionnaire to assess OHRQoL. 
OHRQoL was strongly correlated to SF-12 MCS with 
worse OHRQoL being associated with worse SF-12 
MCS levels. This association may indicate that oral 
impacts may be of sufficient magnitude or duration to 
compromise the overall quality of life. Previous litera-
ture has shown that OHRQoL was significantly corre-
lated with psychological factors, such as depression and 
anxiety (24). On the other hand, another study suggest-
ed that patients view their oral health as impaired only 
if the symptoms of disease affect their functioning. In 
the same way, it is suggested that the functioning of the 
mouth or body could be seen as a link between HRQoL 
and OHRQoL (25). Our findings somehow support this 
point since we found a significant association between 
OHRQoL and SF-12 domains, with physical functioning 
being one of the most impaired SF-12 domains and the 
same was the case for OHIP-14 (functional limitation) 
and OIDP (difficulty eating and difficulty speaking). 
Multivariate models may facilitate understanding of the 
factors that influence HRQoL and therefore are poten-
tially useful for the development of interventions aim-
ing to improve HRQoL (13). Although socio-economic 
status is a well-known predictor of disease morbidity or 
mortality rates, there is controversy about its associa-
tion with HRQoL in the literature (26,27). In our study, 
social class was not associated with HRQoL. As in pre-
vious studies (10,28), clinical variables such as clinical 
                                                              PCSa                                                                 MCSb
Variable                            ß-coefficient [95% CI]                p-value               ß-coefficient [95% CI]                  p-value 
Model 1c
   OHIP-14d                          -0.22 [-0.38-(-0.06)]                0.007              -0.50 [-0.64-(-0.34)]               < 0.001 
   Age (years)                       -0.31 [-0.45- (-0.13)]              <0.001                - 0.02 [-0.15--0.11]                 0.756 
   Sex (male)                           -0.14 [-7.34--0.47]                 0.084                   -0.00 [-3.51-3.71]                  0.957 
   Diseasese                              -0.03 [-5.81-4.25]                 0.760                      
   OIDPf                               -0.21 [-0.24-(-0.03)]                0.010                -0.45 [-0.40-(-0.21)]             < 0.001 
   Age (years)                      -0.33 [-0.46- (-0.14)]              <0.001                    -0.04 [-0.17-0.10]                0.573       
   Sex (male)                            -0.14 [-7.41-0.42]                0.080                     -0.00 [-3.70-3.62]                0.983 
   Diseasese                              -0.02 [-5.69-4.42]                0.803                
Model 2g
   OHIP-14d                         -0.22 [-0.38-(-0.07)]                 0.006               -0.50 [-0.63-(-0.34)]              < 0.001
    Age (years)                     -0.33 [-0.45- (-0.16)]               <0.001 
    Sex (male)                            -0.14 [-7.31-0.48]                 0.085 
   OIDPf                                -0.21 [-0.24-(-0.04)]                 0.008              -0.47 [-0.39-(-0.21)]             < 0.001 
   Age (years)                       -0.34 [-0.45- (-0.17)]               <0.001                    
   Sex (male)                              -0.14 [-7.37-0.43]                 0.081
Table 3. Multiple linear regression models predicting SF-12 Physical Component Summary and SF-12 Mental Component Summary 
scores in patients treated for oral cancer (n=142).
a Physical Component Summary; b Mental Component Summary; c Method Enter; d Oral Health Impact Profile; e Presence vs. no pres-
ence of diseases; f Oral Impacts on Daily Performances; g Method Backforward (removal >0.10).
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stage, follow-up or type of treatment were not signifi-
cantly associated with HRQoL in bivariate analyses. 
This could be partly due to the fact that our patients 
were evaluated at least 6 months after treatment. First, 
differences in HRQoL for clinical stage tend to be mini-
mized over time (15). Second, the impairments in oral 
cancer patients can last a long time which would ex-
plain that more time of follow-up was not correlated to 
worse HRQoL. Finally, differences in HRQoL accord-
ing to type of treatment are related to oral symptoms 
(15), that it is to say, they are more related to OHRQoL 
than HRQoL. 
OHRQoL was the only variable to be associated to both 
HRQoL components and was the only variable in the 
MCS model. Furthermore, it is noteworthy that OHR-
QoL accounted for a considerable percentage of the to-
tal variance in the MCS (23.9% for OHIP and 21.8% for 
OIDP). For the PCS, OHRQoL, age and sex explained 
16.5% of the total variance when the OHIP-14 was used 
and 16.1% when the OIDP was used.
In line with other studies (7,27,29) older patients had 
significantly worse HRQoL scores a long-time after 
treatment than younger patients. There is incongruence 
in the literature regarding the role of gender in deter-
mining HRQOL (29) we found that women had worse 
PCS scores than men. Age and sex are biological char-
acteristics that may help identify patients most likely 
to benefit from supportive care options. From a public 
health point of view, it is important to highlight that 
OHRQoL is the only variable in the multivariate models 
that it is amenable to modification though interventions. 
The negative significant association between OHRQoL 
and both PCS and MCS indicates that focusing on fac-
tors that might positively influence OHRQoL could po-
tentially contribute to improving HRQoL.
This study has some limitations. A first potential limita-
tion related to the use of non-specific disease question-
naires. Because oral cancer is such a disabling condition, 
it is quite likely that the vast majority of the reported oral 
impacts would relate to this condition or its treatment. 
This could have been addressed through the additional 
use of a cancer-specific OHRQoL measure. The OIDP 
has a condition specific feature that attributes oral im-
pacts to specific conditions (30), oral cancer in this case. 
It was not used in this study to avoid increasing data col-
lection time and reduce the efficiency of the study. Nev-
ertheless, generic questionnaires are beneficial in other 
respects as they are conceptually broader and cover large 
aspects of a person’s health (13). Second, we did not have 
information on other factors that may also be influence 
HRQoL such as marital status or behaviors like alcohol or 
smoking. Future research should include cancer-specific 
assessment of OHRQoL and consider other factors that 
could be associated with the change in long-term HRQoL 
in oral and oropharyngeal cancer patients.
In conclusion, There was a significant association be-
tween long-term OHRQoL and HRQoL in oral and 
oropharyngeal cancer patients, ever after adjusting for 
confounding factors. OHRQoL could be an important 
factor determining HRQoL, particularly SF-12 MCS. 
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